Quantcast Acelity - Newsroom
MENU

Newsroom


News Releases

  • May 16, 2019
    KCI Announces Significant Advancement in Negative Pressure Wound Therapy Drape Technology
    Details
  • May 9, 2019
    PREVENA™ Therapy Becomes the First and Only Negative Pressure Medical Device FDA-Indicated to Aid in the Reduction of Superficial Surgical Site Infections (SSIs) in Patients at High Risk for Post-Operative Infections
    Details
  • May 2, 2019
    Apax Funds, CPPIB and PSP Investments Agree to Sell Acelity and its KCI Subsidiaries to 3M for $6.725 Billion
    Details
  • April 18, 2019
    KCI Files Registration Statement for Proposed Initial Public Offering
    Details

Upcoming Events

Footer Navigation